Avi Avramoff
Chief Tech/Sci/R&D Officer bei TARO PHARMACEUTICAL INDUSTRIES LTD.
Profil
Avi Avramoff is currently the Vice President & Head of Research & Development at Taro Pharmaceutical Industries Ltd.
Prior to his current position, he served as the Vice President of Research & Development at Dexcel Pharma Technologies Ltd.
from 1994 to 2011.
Aktive Positionen von Avi Avramoff
| Unternehmen | Position | Beginn |
|---|---|---|
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Chief Tech/Sci/R&D Officer | 01.10.2011 |
Ehemalige bekannte Positionen von Avi Avramoff
| Unternehmen | Position | Ende |
|---|---|---|
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Chief Tech/Sci/R&D Officer | 01.01.2011 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |
